Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 10Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Hepatocellular 20Carcinoma, Renal Cell 16Liver Neoplasms 7Leukemia, Myeloid, Acute 3Thyroid Neoplasms 2Financial Stress 2Carcinoma 2Patient Preference 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Kidney Neoplasms 1Colorectal Neoplasms 1Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Adenoma, Islet Cell 1

Interventions

temsirolimus 2Sunitinib 2Sorafenib 2Axitinib 2sonidegib 1niraparib 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1Transurethral Resection of Prostate 1Therapeutics 1Phlebotomy 1Palliative Care 1Mitomycin 1Methylation 1Maintenance 1Interviews as Topic 1Hyperthermic Intraperitoneal Chemotherapy 1HhAntag691 1Hepatectomy 1Fatty Acids, Omega-6 1Endoscopy 1Cetuximab 1Breath Tests 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Carcinoma × Sorafenib × Clear all
NCT00771147 2012-06-15

PONDIAC

Bayer

Completed
71 enrolled
Genitourinary

Carcinoma, Carcinoma, Renal Cell

NCT00895674 2010-09-30

Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar

Bayer

Completed
2,840 enrolled
Genitourinary

Carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡